Clinical Trial

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Name: Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib — clinical trial record (NCT06899061)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase I modular study to assess the effect of oral saruparib on other treatments in patients with advanced solid malignancies.

Protocol Amendment History 1 change

minor Completion pushed: 2026-04-30 -> 2028-05-19 2026-07-31

Trial Details

NCT Number	NCT06899061
Lead Sponsor	AstraZeneca Collaborators: Parexel
Conditions	Advanced Solid Malignancies
Enrollment	41 participants
Start Date	2025-03-25
Primary Completion	2026-02-03 (estimated)
Study Completion	2028-05-19 (estimated)
Updated on ClinicalTrials.gov	2026-07-30